Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ: PRE )

0.8000 +0.0500 (+6.67%)
Streaming Delayed Price Updated: 1:58 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Prenetics Global Limited - Class A Ordinary Share

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology 
From Prenetics Limited
Via Globe NewsWire
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
From Prenetics Limited
Via Globe NewsWire
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Prenetics Limited
Via Globe NewsWire
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
From Prenetics Global Limited
Via ACN Newswire
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
From Prenetics Limited
Via Globe NewsWire
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
From Prenetics Limited
Via Globe NewsWire
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
From Prenetics Limited
Via Globe NewsWire
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics
From Prenetics Global Limited
Via ACN Newswire
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
From Prenetics Limited
Via Globe NewsWire
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
From Prenetics Global Limited
Via ACN Newswire
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Via ACN Newswire
Exposures COVID-19
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
From Prenetics Limited
Via Globe NewsWire
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
Via ACN Newswire
Exposures COVID-19
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market
Via ACN Newswire
Above Phone partners with Presearch on secure, private phone
Above Phone will now ship with Presearch as default web browser and search engine. 
Via IssueWire
Citi Initiates Coverage on Prenetics Global with "Buy" Rating, Target Price at USD8.10
Via ACN Newswire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.